Kevin Doyle

Group Leader, Lead Optimization, Charles River

Kevin is a medicinal chemist in Discovery Research Services who works on diverse biological targets including kinases, ion channels, and GPCRs and across multiple therapeutic areas. Prior to Charles River, Kevin was a senior scientist at OSI Pharmaceuticals and Knoll (BASF Pharma).